Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock
Authors:
- 1 May 2020
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 13 (10) , 1171-1178
Abstract
No abstract availableKeywords
Funding Information
- Edwards Lifesciences
- Boston Scientific Corporation
- Medtronic
- St. Jude Medical
This publication has 16 references indexed in Scilit:
- PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic ShockNew England Journal of Medicine, 2017
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2017
- Fractional Flow Reserve–Guided Multivessel Angioplasty in Myocardial InfarctionNew England Journal of Medicine, 2017
- Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary InterventionCirculation Research, 2017
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial InfarctionJACC, 2016
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEuropean Heart Journal, 2015
- Randomized Trial of Preventive Angioplasty in Myocardial InfarctionNew England Journal of Medicine, 2013
- Use and Outcomes of Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (from the EHS-PCI Registry)The American Journal of Cardiology, 2012
- Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial InfarctionJACC, 2011
- Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: The second National Registry of Myocardial InfarctionAmerican Heart Journal, 2001